Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 207921

Expand all

QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE)
0.04MG/INH
Marketing Status: Prescription
Active Ingredient: BECLOMETHASONE DIPROPIONATE
Proprietary Name: QVAR REDIHALER
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.04MG/INH
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207921
Product Number: 001
Approval Date: Aug 3, 2017
Applicant Holder Full Name: NORTON WATERFORD LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE)
0.08MG/INH
Marketing Status: Prescription
Active Ingredient: BECLOMETHASONE DIPROPIONATE
Proprietary Name: QVAR REDIHALER
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.08MG/INH
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207921
Product Number: 002
Approval Date: Aug 3, 2017
Applicant Holder Full Name: NORTON WATERFORD LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English